UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042504
Receipt number R000048523
Scientific Title Effect of ripasudil on corneal endothelial damage after glaucoma tube shunt surgery
Date of disclosure of the study information 2020/12/25
Last modified on 2023/11/21 15:45:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of ripasudil on corneal endothelial damage after glaucoma tube shunt surgery

Acronym

Effect of ripasudil on corneal endothelial damage after glaucoma tube shunt surgery

Scientific Title

Effect of ripasudil on corneal endothelial damage after glaucoma tube shunt surgery

Scientific Title:Acronym

Effect of ripasudil on corneal endothelial damage after tube shunt surgery

Region

Japan


Condition

Condition

glaucoma

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of ripasudil on corneal endothelial damage after glaucoma tube shunt surgery.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

corneal endothelial cell density during 2 years after surgery

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

ripasudil eye drop 2 times/day for 2 years

Interventions/Control_2

no ripasudil eye drop

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients who can be obtained informed consent
patients who have glaucoma tube shunt surgery

Key exclusion criteria

significant corneal endothelial damage
pregnancy
eye surgery within 6 months

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kazuyuki
Middle name
Last name Hirooka

Organization

Hiroshima University Hospital

Division name

ophthalmology

Zip code

734-8551

Address

Kasumi 1-2-3 Minami-ku, Hiroshima

TEL

082-257-5555

Email

onoehir@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Kazuyuki
Middle name
Last name Hirooka

Organization

Hiroshima University Hospital

Division name

ophthalmology

Zip code

734-8551

Address

Kasumi 1-2-3 Minami-ku, Hiroshima

TEL

082-257-5555

Homepage URL


Email

kazuyk@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University Hospital

Institute

Department

Personal name



Funding Source

Organization

Hiroshima University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8551

Tel

0822571551

Email

iryo-seisaku@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛媛大学医学部附属病院(愛媛県)、ツカザキ病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 11 Month 19 Day

Date of IRB

2020 Year 12 Month 22 Day

Anticipated trial start date

2021 Year 01 Month 04 Day

Last follow-up date

2028 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 11 Month 19 Day

Last modified on

2023 Year 11 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048523


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name